WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005123086) ZIPRASIDONE DOSAGE FORM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/123086    International Application No.:    PCT/US2005/020417
Publication Date: 29.12.2005 International Filing Date: 09.06.2005
IPC:
A61K 9/14 (2006.01), A61K 9/16 (2006.01), A61K 9/50 (2006.01), A61K 31/496 (2006.01), A61K 31/555 (2006.01), A61K 31/50 (2006.01), A61K 31/497 (2006.01), A01N 43/00 (2006.01), A01N 55/02 (2006.01), A01N 43/58 (2006.01)
Applicants: DR. REDDY'S LABORATORIES LTD. [IN/IN]; 7-1-27 Ameerpet, Hyderabad 500 016 (IN) (For All Designated States Except US).
DR. REDDY'S LABORATORIES, INC. [US/US]; 200 Somerset Corporate Boulevard, 7th floor, Bridgewater, NJ 08807 (US) (For All Designated States Except US).
VIBHUTHI, Gouri Shankar [IN/IN]; (IN) (For US Only).
AGRAWAL, Sudeep Kumar [IN/IN]; (IN) (For US Only).
REDDY, Billa Praveen [IN/IN]; (IN) (For US Only).
KRISHNAN, Kiran [IN/US]; (US) (For US Only).
MOHAN, Mailatur Sivaraman [IN/IN]; (IN) (For US Only)
Inventors: VIBHUTHI, Gouri Shankar; (IN).
AGRAWAL, Sudeep Kumar; (IN).
REDDY, Billa Praveen; (IN).
KRISHNAN, Kiran; (US).
MOHAN, Mailatur Sivaraman; (IN)
Agent: FRANKS, Robert A.; Dr. Reddy's Laboratories, Inc., Patent Prosecution Group, 200 Somerset Corporate Boulevard ||7th floor, Bridgewater, NJ 08807 (US)
Priority Data:
546/CHE/2004 11.06.2004 IN
Title (EN) ZIPRASIDONE DOSAGE FORM
(FR) FORME DE DOSAGE DE ZIPRASIDONE
Abstract: front page image
(EN)Pharmaceutical formulations of ziprasidone comprise ziprasidone or a salt thereof, in the form of particles having a mean particle size greater than about 90 µm and a pharmaceutically acceptable excipient.
(FR)L'invention concerne des formulations pharmaceutiques de ziprasidone comprenant de la ziprasidone ou un de ses sels, sous forme de particules, de dimension particulaire moyenne supérieure à approximativement 90 $g(m)m, ainsi qu'un excipient compatible sur le plan pharmaceutique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)